AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER Breast Cancer When Administered Using Intermittent or Continuous Schedules (Q38836223)
Jump to navigation
Jump to search
scientific article published on 10 September 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER Breast Cancer When Administered Using Intermittent or Continuous Schedules |
scientific article published on 10 September 2015 |
Statements
1 reference
AZD2014, an Inhibitor of mTORC1 and mTORC2, Is Highly Effective in ER Breast Cancer When Administered Using Intermittent or Continuous Schedules (English)
1 reference
Sylvie M Guichard
1 reference
Jon Curwen
1 reference
Teeru Bihani
1 reference
Celina M D'Cruz
1 reference
James W T Yates
1 reference
Michael Grondine
1 reference
Zoe Howard
1 reference
Barry R Davies
1 reference
Graham Bigley
1 reference
Teresa Klinowska
1 reference
Kurt G Pike
1 reference
Martin Pass
1 reference
Christine M Chresta
1 reference
Urszula M Polanska
1 reference
Robert McEwen
1 reference
Oona Delpuech
1 reference
Stephen Green
1 reference
Sabina C Cosulich
1 reference
10 September 2015
1 reference
1 reference
14
1 reference
11
1 reference
2508-2518
1 reference
Identifiers
1 reference
1 reference